Article Text

Download PDFPDF
Clopidogrel plus aspirin did not differ from aspirin alone for reducing MI, stroke, and CV death in high risk atherothrombosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr E J Topol, Case Western Reserve University, Cleveland, Ohio, USA. eric.topol{at}

  • Sources of funding: Sanofi-Aventis; Bristol-Myers Squibb; National Institutes of Health.

Linked Articles

  • Glossary
    BMJ Publishing Group Ltd